BOCOM INTL: EAST BUY (01797) "Neutral" rating with target price raised to 15.6 Hong Kong dollars.
The operating revenue of Dongfang Zhuxuan decreased by 9% compared to the first half of the 2025 fiscal year ending on November 30 of last year.
BOCOM INTL released a research report stating that, considering the decrease in shares, the target price of EAST BUY (01797) has been increased from 14.9 Hong Kong dollars to 15.6 Hong Kong dollars, with a rating of "neutral".
The report mentioned that as of the first half of the 2025 fiscal year ending November 30th of last year, EAST BUY's ongoing operating revenue decreased by 9% year-on-year. Excluding the financial impact of selling "Yuhui Together", the adjusted net profit from ongoing operations was 32.70 million Chinese yuan, with short-term financial performance being affected by business adjustments during the period.
BOCOM INTL stated that they have observed a trend of business recovery for the company, with the gross profit margin showing growth. It is expected that EAST BUY will continue to focus on developing self-owned products, establishing brand influence, increasing APP membership, and strengthening resource synergy with NEW ORIENTAL-S (09901). With the recent introduction of gift-giving functionality on WeChat mini shops, EAST BUY is expected to explore potential new sales channels and lay the foundation for attracting new users. It is anticipated that financial data will bottom out in the 2025 fiscal year and stabilize growth thereafter.
Related Articles

HK Stock Market Move | Weichai Power (02338) rose more than 4% in the morning trading session. Sales of engines for data centers reached 1400 units for the year, an increase of 259% compared to the previous year.

HK Stock Market Move | BAO PHARMA-B (02659) rose nearly 4% in the intraday trading session. The injection-grade human hyaluronidase KJ017 has been approved by the National Medical Products Administration for market launch.
Orientation: FVTPL assets lead to differentiation in insurance performance. It is recommended to allocate resources to the sector at low points.
HK Stock Market Move | Weichai Power (02338) rose more than 4% in the morning trading session. Sales of engines for data centers reached 1400 units for the year, an increase of 259% compared to the previous year.

HK Stock Market Move | BAO PHARMA-B (02659) rose nearly 4% in the intraday trading session. The injection-grade human hyaluronidase KJ017 has been approved by the National Medical Products Administration for market launch.

Orientation: FVTPL assets lead to differentiation in insurance performance. It is recommended to allocate resources to the sector at low points.





